NTRA
What one share of Natera holds
Services – Medical Laboratories
We are a diagnostics company with proprietary molecular and bioinformatics technology that we are applying to change disease management worldwide.
Natera’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $19.32 |
|---|---|
| Profit | −$1.37 |
| Capex (buildings and equipment) | $1.03 |
| Free cash flow | $0.60 |
| Cash and investments | $7.60 |
| Book value | $12.68 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $4.21 | −$1.95 | $0.45 | −$1.88 | — | $2.73 |
| 2017 | $3.94 | −$2.59 | $0.18 | −$2.01 | — | $0.47 |
| 2018 | $4.45 | −$2.22 | $0.07 | −$1.29 | — | $0.52 |
| 2019 | $4.35 | −$1.79 | $0.07 | −$0.98 | — | $3.57 |
| 2020 | $4.83 | −$2.84 | $0.24 | −$2.49 | — | $5.64 |
| 2021 | $6.91 | −$5.21 | $0.45 | −$4.16 | — | $6.87 |
| 2022 | $8.33 | −$5.57 | $0.48 | −$4.87 | — | $6.34 |
| 2023 | $9.41 | −$3.78 | $0.34 | −$2.49 | — | $6.40 |
| 2024 | $13.61 | −$1.53 | $0.53 | $0.56 | — | $9.01 |
| 2025 | $16.87 | −$1.52 | $0.78 | $0.80 | — | $12.26 |